Non Intrusive
COVID Test
Key Features
Rapid test kits are supplied by a world leading rapid test provider.
- Supplied in kits of 25 tests (£390 inc VAT)
- Test time: 15 minutes
- Storage temperature 2°C to 30°C
- Shelf Life 1 year
- Sensitivity: 97.3%
- Specificity: 99%
- Sample type: Sputum saliva swab
- MHRA Registered and ISO 13485 Certification
- CE Certification – Declaration of Conformity
- Clinical Nursing specialist support available
- Project and quarantine support services
Buy Now
5% checkout discount code : SOTERIA
Our partners Private Harley Street Clinic will complete your order.
Point of Care Rapid
Response Saliva Testing
Soteria UK Limited can provide a Non Intrusive Rapid Saliva Test Device, to determine if a person currently has COVID-19 at the point of care in less than 15 minutes without the need to send the sample to a laboratory.
The COVID-19 test can quickly and qualitatively detect the nucleocaspid protein of novel coronavirus (SARS-COV-2) in human sputum/swab samples. The specimens are analysed at the point of care without the need for additional equipment.
Additional Services
We can provide clinical nursing specialists, GMC registered doctor, administration check-in assistant, positive result quarantine and project management support services if required.
Rapid Saliva Clinical Report
Rapid Saliva Test Information
How is a Rapid Antigen Test taken?
An antigen test detects the presence of viral RNA. Usually, this requires taking a swab from the nose and throat and then analysing the specimen in the lab using the polymerase chain reaction (PCR). This new innovative technology now allows sputum saliva to be used instead of intrusive methods such as nasal intrusive testing.
- It aims to see if the virus is detectable now and is taken to diagnose infection
- Test following infection to see if the virus has been cleared
- Screen asymptomatic individuals to detect if they carry virus and are potentially infectious
These tests are a crucial part of mitigating transmission as we come out of lockdown. We need the ability to detect the carriage of covid-19 and respond to it rapidly. As people return to work and society tentatively re-opens, robust testing programmes as part of a return to work strategy will be key to reduce spread and improve confidence amongst employees and customers.
